Commitments and Contingencies (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended
	Feb. 05, 2024	Nov. 03, 2020	Oct. 25, 2019	Mar. 31, 2024
Payments For Future Research And Collobration				$ 1,344,784
Total Grants Repayable				468,668
Principal balance payable				261,869
Aggerate Amount Payable, Description		under this Agreement will be completed by the end of the third quarter of 2024 at a total additional cost to the Company of up to $0.7 million
Loan agreement, Description	a 9-month loan agreement with First Insurance Funding for a maximum of $294,603 with fixed interest rate of 8.42%, maturing in November 2024
Total Long-Term Debt				4,522,512
Amount payable for services rendered				130,883
Amount may be payable by Company in future periods for services rendered				696,920
Accrued compensation expense				536,535
Recognized total compensation expense				$ 335,437
Tamu [Member]
Debt conversion, Converted instrument, Rate			7.50%
Additional interest			5.00%
Equity Interest			12.50%	12.50%
Restricted Stock Units [Member]
Recognized total compensation expense				$ 1,184,860
RSU Vested in 2024				388,561
RSU Vested in 2023				527,940
RSU Vested in 2025				268,359
Unrecognized compensation expense				392,093
Two Thousand Twenty Two [Member] | Univercity Of Texas MD [Member]
Collaborative Obligations Amount Due				449,406
Additional Cost Of Company				449,406
August Two Thousand Twenty Three [Member] | Guy's and St Thomas' NHS Foundation Trust [Member]
Collaborative Obligations Amount Due				40,992
Additional Cost Of Company				40,992
Cost				163,966
July Thirty One Thousand Twenty Three [Member] | Xenetic Biosciences Inc and CLS Therapeutics [Member]
Collaborative Obligations Amount Due				26,142
Additional Cost Of Company				81,447
Cost				107,589
RSU 2026 [Member]
Unrecognized compensation expense				299,364
January TwoThousand Twenty Four [Member] | University Medical Centre Amsterdam[Member]
Collaborative Obligations Amount Due				139,965
Additional Cost Of Company				139,965
Cost				139,965
RSU 2025 [Member]
Unrecognized compensation expense				268,899
RSU 2024 [Member]
Unrecognized compensation expense				177,800
RSU 2023 [Member]
Unrecognized compensation expense				746,063
Managing Director's Agreement [Member]
Amount payable				211
Royalty Payment				118,918
Clinical Study Research Agreement [Member] | University of Taiwan [Member] | In 2018 [Member]
Collaborative Obligations Amount Due				510,000
Collaborative Obligations Amount				$ 2,550,000
Lease Agreement Expire Period				3 years
Operating Lease Right of Use Obligations [Member]
Payment Of Lease Liabilities				$ 65,166
Operating Lease Expense				65,660
Short Term Lease Costs				$ 29,961